Literature DB >> 23040712

Number of lymph nodes removed during modified radical neck dissection for papillary thyroid cancer does not influence lateral neck recurrence.

Maria B Albuja-Cruz1, Chad M Thorson, Bassan J Allan, John I Lew, Steven E Rodgers.   

Abstract

BACKGROUND: This study examines the relationship between the number of lymph nodes removed during modified radical neck dissection and the incidence of disease recurrence.
METHODS: A retrospective review of 117 patients with papillary thyroid cancer and lateral neck involvement (levels 2-5) who underwent modified radical neck dissection was performed. Data were analyzed for patient demographics, operative procedure, lymph node involvement, complications, radioactive iodine therapy, and disease recurrence.
RESULTS: Of 117 patients who underwent modified radical neck dissection, the median follow-up of the entire study group was 25 months (range, 1-256 months). Recurrent disease was found in 8% of patients, with a median time to recurrence of 35 months. The median number of lymph nodes removed during modified radical neck dissection was similar in recurrent and nonrecurrent patients (P = .78). There was also no difference in the median number of positive lymph nodes removed (P = .14) between these 2 groups. On multivariate analysis, however, the number of positive lymph nodes (odds ratio, 1.16 [95% confidence interval, 1.01-1.34]) and tumor size (odds ratio, 1.60 [95% confidence interval, 1.03-2.49]) were independent predictors of recurrence of disease after modified radical neck dissection.
CONCLUSION: Recurrence of papillary thyroid cancer after modified radical neck dissection is unrelated to the number of lymph nodes removed. This study suggests that attempts to maximize the number of lymph nodes removed during modified radical neck dissection for papillary thyroid cancer may not be necessary.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23040712     DOI: 10.1016/j.surg.2012.08.025

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).

Authors:  Wen-Jun Wei; Zhong-Wu Lu; Duo Wen; Tian Liao; Duan-Shu Li; Yu Wang; Yong-Xue Zhu; Zhuo-Ying Wang; Yi Wu; Yu-Long Wang; Qing-Hai Ji
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

Review 2.  Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis.

Authors:  Kai Guo; Zhuoying Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Pattern of nodal involvement in papillary thyroid cancer: a challenge of quantitative analysis.

Authors:  Fausto Fama; Marco Cicciù; Giuseppe Lo Giudice; Alessandro Sindoni; Jessica Palella; Arnaud Piquard; Olivier Saint-Marc; Salvatore Benvenga; Ennio Bramanti; Gabriele Cervino; Maria Gioffre Florio
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Ultrasonographic findings relating to lymph node metastasis in single micropapillary thyroid cancer.

Authors:  Yoon Se Lee; Yun-Sung Lim; Jin-Choon Lee; Soo-Geun Wang; Seok-Man Son; Sang-Soo Kim; In-Ju Kim; Byung-Joo Lee
Journal:  World J Surg Oncol       Date:  2014-08-28       Impact factor: 2.754

5.  The influence of cervical lymph node number of neck dissection on the prognosis of the early oral cancer patients.

Authors:  Chieh-Yuan Cheng; Fang-Ju Sun; Chung-Ji Liu
Journal:  J Dent Sci       Date:  2020-06-07       Impact factor: 2.080

6.  Papillary thyroid cancer: the value of bilateral diagnostic lymphadenectomy.

Authors:  Jagdeep Singh Bhangu; Christoph Bichler; Julia Altmeier; Lindsay Hargitai; Andreas Selberherr; Peter Mazal; Jonas Brugger; Christian Scheuba; Philipp Riss; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2022-03-17       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.